Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

AARNO LABS LLC

UEI: E24AMLJUN625CAGE: 71TF0

AARNO LABS LLC is a federal contractor, registered under UEI E24AMLJUN625 and CAGE code 71TF0. It has been awarded $26,451,596 across 14 federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), Research and Development in Biotechnology (except Nanobiotechnology), and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Defense, Department Of Defense (dod), and Department Of The Interior.

Contact Information

Registration and classification details

Registration

UEI Code

E24AMLJUN625

CAGE Code

71TF0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

2XLJ

NAICS Codes

541511Custom Computer Programming Services
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

AARNO LABS LLC specializes in advanced research and development across physical, engineering, and life sciences, with a demonstrated focus on defense-critical software systems and biotechnology innovation. Their core capabilities include software interposition frameworks, secure application layer an...

AARNO LABS LLC specializes in advanced research and development across physical, engineering, and life sciences, with a demonstrated focus on defense-critical software systems and biotechnology innovation. Their core capabilities include software interposition frameworks, secure application layer analysis, and enhanced software bill of materials (SBOM) technologies for sustainment and supply chain integrity. The firm has delivered cutting-edge solutions for the Defense Advanced Research Projects Agency, particularly in Android application interposition and SBOM optimization, showcasing deep expertise in runtime instrumentation, system-level software analysis, and secure software lifecycle management. Their technical proficiency spans low-level system interposition, dynamic code analysis, and secure software supply chain practices, distinguishing them as a nimble innovator in defense-critical software assurance. The company maintains a consistent relationship with the Department of Defense, delivering high-impact R&D under SBIR and incremental funding mechanisms. Their work supports DARPA’s mission to advance next-generation defense technologies, with projects spanning secure mobile application analysis, biotechnological research tools, and software sustainment frameworks critical to military IT resilience. AARNO LABS operates primarily within NAICS 541712, 541714, and 541715, focusing on non-biotech and non-nanotech R&D in engineering and life sciences, with a clear emphasis on software-centric defense applications. Their market positioning is that of a specialized small business contractor serving high-barrier, innovation-driven defense programs requiring deep technical agility and rapid prototyping. As a 2L entity based in Cambridge, MA, AARNO LABS LLC is a small, agile firm without federal certifications, yet it commands credibility through direct delivery of classified and sensitive R&D projects for the DoD. Its geographic proximity to leading academic and defense research hubs enhances its ability to attract specialized talent and collaborate on advanced technical initiatives.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Defense$21.1M79.8%
Department Of Defense (dod)$3.7M13.9%
Department Of The Interior$1.6M6.2%
Awards by NAICS
Export
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)$16.7M63%
541714 - Research and Development in Biotechnology (except Nanobiotechnology)$5.9M22.2%
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)$3.2M12.2%
- Unknown NAICS$704.2K2.7%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in AARNO LABS LLC's top NAICS codes and agencies

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.
W6QK Acc-Apg

POSTED

about 17 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Army Contracting Command – Red River Army Depot (ACC-RRAD) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911RQ-26-S-C001
The U.S. Army, through the Army Contracting Command – Red River Army Depot, is pursuing the modernization of its Organic Industrial Base under Commercial Solutions Opening W911RQ-26-S-C001, a flexible procurement initiative authorized under DFARS Subpart 212.70 and administered under FAR Part 12 Commercial Item Procedures. This effort is aligned with the Army’s strategic focus on Convergent Manufacturing, integrating advanced technologies such as digital twin, automation, connected digital enterprise, and cybersecurity to enhance producibility, sustainment, and logistics capabilities. The solicitation invites innovative commercial solutions across multiple areas of interest including automated media blast systems, camera monitoring for vehicle test tracks, power pack interface and test sets, AS9100 certification support, track pin and bushing manufacturing, and fixture removal for Bradley Fighting Vehicle hulls. Each area of interest is evaluated independently with specific submission deadlines, and all responses must be submitted electronically via email in two separate volumes: a technical proposal excluding cost data and a price proposal with full cost breakdowns, including labor rates, material quotes, and overhead. Offers must be unclassified, submitted through SAM.gov-registered entities with a Unique Entity ID, and adhere to strict formatting rules including a maximum of five pages or fifteen slides for initial solution briefs. Evaluation of proposals prioritizes technical merit and feasibility, followed by industrial base impact, speed and scalability of implementation, price fairness and reasonableness, private investment leverage, and a credible transition plan to full production. The government will use a trade-off approach rather than lowest price technically acceptable, with no numerical weights assigned but clear emphasis on non-price factors. Awards are contingent upon funding availability, successful negotiation, and technical validation, and do not obligate the government to proceed with any contract until formal award. Performance is expected to occur at Red River Army Depot in Texarkana, Texas, with inspection and acceptance conducted by the government at that location per MIL-DTL-11891, MIL-STD-1907, ASTM, and other referenced standards covering material quality, inspection, and manufacturing processes. Contractors must register in Wide Area Work Flow for invoicing, and proposals must comply with secure-by-design principles and modular open systems architecture requirements. No contract clauses, special requirements, or detailed packaging and marking specifications are provided in the solicitation, leaving these to be defined during contract negotiation post-selection. All submissions must be received by 5:00 P.M. CDT on their respective
W6QK Acc Rrad

POSTED

about 17 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells
Solicitation # NIH-NOI-PCA-NIA-01590
The National Institute on Aging (NIA), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for the validation and optimization of ONE-STEP tagging in human induced pluripotent stem cells (iPSCs). This acquisition aims to support the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer’s Disease and Related Dementias (CARD) by generating functionally engineered iPSC lines for research into Alzheimer’s disease and related dementias. The project involves high-activity guide identification, Bxb1 mRNA and cargo plasmid delivery optimization, and the generation of ADRD variant, MAPT 4R, and wild-type process-control clones. All deliverables must be repository-ready, meeting strict quality control standards including long-read sequencing, karyotype analysis, and SNP arrays to ensure scientific continuity and data integrity. The government intends to award this contract to The Jackson Laboratory, citing them as the only responsible source capable of meeting the requirements under FAR 6.302-1 and FAR 13.501(a). This determination is based on the laboratory's unique continuity with the existing iNDI program, established workflows for specific background lines, and proven success in large-scale CRISPR/Cas9 engineering. The total estimated contract value is 3,353,115.00 dollars, covering a base year from September 1, 2026, to August 31, 2027, and an option year extending to August 31, 2028. While this is a sole-source intent, the government will consider capability statements from other sources submitted by August 21, 2026, to determine if adequate competition exists.
National Institutes Of Health Olao

POSTED

about 17 hours ago

DEADLINE

in 3 days
View Details